Target intelligence / Profile preview

Rotavirus A VP7 glycoprotein (G9 type) (VP7)

Target
VP7
Molecular classification
Viral protein, Glycoprotein, Capsid protein
01

Overview

Rotavirus VP7 glycoprotein (G9 type) is a major structural protein located on the outer shell of the rotavirus virion. It is a calcium-binding protein that plays a critical role in the initial stages of viral infection, specifically in the attachment and penetration of host intestinal cells. As the primary determinant of the G-serotype, VP7 is a major target for the host's neutralizing antibody response. The G9 serotype has emerged globally as one of the most prevalent strains causing severe diarrhea in children. Therapeutic strategies primarily involve preventive vaccines that utilize live-attenuated strains expressing G9 or other common VP7 types to elicit protective immunity. Vaccines like Rotavac and Rotasiil specifically incorporate the G9 antigen to provide broad protection against circulating strains. Understanding the structural variations in the G9 type is essential for monitoring vaccine efficacy and the emergence of escape mutants.

Other names
VP7G9 antigenOuter capsid glycoprotein VP7Glycoprotein G9Rotavirus G9 type
02

Mechanism of action

Induction of neutralizing antibodies that bind to the VP7 glycoprotein, blocking viral attachment to host cells and preventing the calcium-dependent uncoating of the viral particle.

03

Biological functions

Viral entryHost-virus interactionCalcium ion bindingViral capsid assemblyViral attachment
04

Disease associations

InfectionGastroenteritis
05

Safety considerations

IntussusceptionAntigenic driftVaccine-derived reassortmentStrain replacement
06

Interacting drugs

Rotavac (116E)

3 more in the full profile.

07

Biomarkers

Serum anti-rotavirus IgAVP7-specific neutralizing antibodiesViral G-genotyping via RT-PCR

Beyond the preview

Go deeper on Rotavirus A VP7 glycoprotein (G9 type) (VP7).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rotavirus A VP7 glycoprotein (G9 type) (VP7).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call